prostate cancer

Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer

European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn about a recent paper by Chris Parker et al. published in The Lancet.

“Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial”

Authors: Chris Parker, Noel Clarke, Adrian Cook, Mahesh Parmar, Matthew Sydes et al.

Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer

“Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer, published in The Lancet.

Read it before your patients.”

Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer

Source: ESTRO/LinkedIn

Adrian Cook ADT androgen deprivation therapy cancer Chris Parker ESTRO European SocieTy for Radiotherapy and Oncology Mahesh Parmar Matthew Sydes Noel Clarke OncoDaily Oncology prostate cancer RADICALS-HD The Lancet